A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Venancio Avancini Ferreira et al. Pâncreas exócrino. Bogliolo Patologia. Tradução . Rio de Janeiro: Guanabara Koogan, 2022. . . Acesso em: 25 set. 2024.
APA
Alves, V. A. F., Segatelli, V., Claro, L. C. L., & Mello, E. S. de. (2022). Pâncreas exócrino. In Bogliolo Patologia. Rio de Janeiro: Guanabara Koogan.
NLM
Alves VAF, Segatelli V, Claro LCL, Mello ES de. Pâncreas exócrino. In: Bogliolo Patologia. Rio de Janeiro: Guanabara Koogan; 2022. [citado 2024 set. 25 ]
Vancouver
Alves VAF, Segatelli V, Claro LCL, Mello ES de. Pâncreas exócrino. In: Bogliolo Patologia. Rio de Janeiro: Guanabara Koogan; 2022. [citado 2024 set. 25 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Gilton M. et al. Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter?. Scandinavian journal of surgery, v. 111, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1177/14574969211069329. Acesso em: 25 set. 2024.
APA
Fonseca, G. M., Mello, E. S. de, Faraj, S. F., Kruger, J. A. P., Jeismann, V. B., Coelho, F. F., et al. (2022). Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter? Scandinavian journal of surgery, 111( 1). doi:10.1177/14574969211069329
NLM
Fonseca GM, Mello ES de, Faraj SF, Kruger JAP, Jeismann VB, Coelho FF, Alves VAF, Herman P. Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter? [Internet]. Scandinavian journal of surgery. 2022 ; 111( 1):[citado 2024 set. 25 ] Available from: https://doi.org/10.1177/14574969211069329
Vancouver
Fonseca GM, Mello ES de, Faraj SF, Kruger JAP, Jeismann VB, Coelho FF, Alves VAF, Herman P. Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter? [Internet]. Scandinavian journal of surgery. 2022 ; 111( 1):[citado 2024 set. 25 ] Available from: https://doi.org/10.1177/14574969211069329
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERROTTA, Fernando Simionato et al. Evaluation of the F-18-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma. Nuclear medicine communications, v. 43, n. 7, p. 823-833, 2022Tradução . . Disponível em: https://doi.org/10.1097/MNM.0000000000001567. Acesso em: 25 set. 2024.
APA
Perrotta, F. S., Ribeiro Junior, U., Mester, M., Mello, E. S. de, Sado, H. N., Pinheiro, R. B. B., et al. (2022). Evaluation of the F-18-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma. Nuclear medicine communications, 43( 7), 823-833. doi:10.1097/MNM.0000000000001567
NLM
Perrotta FS, Ribeiro Junior U, Mester M, Mello ES de, Sado HN, Pinheiro RBB, Tustumi F, Buchpiguel CA, Zilberstein B, Cecconello I. Evaluation of the F-18-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma [Internet]. Nuclear medicine communications. 2022 ; 43( 7): 823-833.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/MNM.0000000000001567
Vancouver
Perrotta FS, Ribeiro Junior U, Mester M, Mello ES de, Sado HN, Pinheiro RBB, Tustumi F, Buchpiguel CA, Zilberstein B, Cecconello I. Evaluation of the F-18-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma [Internet]. Nuclear medicine communications. 2022 ; 43( 7): 823-833.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/MNM.0000000000001567
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMERES, Silas Gustavo Barboza et al. Progressive familial intrahepatic cholestasis type 2 and recurrence after liver transplantation: a case report. Transplantation proceedings, v. 54, n. 5, p. 1370-1375, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.transproceed.2022.04.007. Acesso em: 25 set. 2024.
APA
Romeres, S. G. B., Trevizoli, N. de C., Oliveira, C. A. M. de, Obeid, E. J., Ferreira, G. de S. A., Campos, P. B., et al. (2022). Progressive familial intrahepatic cholestasis type 2 and recurrence after liver transplantation: a case report. Transplantation proceedings, 54( 5), 1370-1375. doi:10.1016/j.transproceed.2022.04.007
NLM
Romeres SGB, Trevizoli N de C, Oliveira CAM de, Obeid EJ, Ferreira G de SA, Campos PB, Ullmann RFB, Rocha HC, Figueira AVF, Mello ES de. Progressive familial intrahepatic cholestasis type 2 and recurrence after liver transplantation: a case report [Internet]. Transplantation proceedings. 2022 ; 54( 5): 1370-1375.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.transproceed.2022.04.007
Vancouver
Romeres SGB, Trevizoli N de C, Oliveira CAM de, Obeid EJ, Ferreira G de SA, Campos PB, Ullmann RFB, Rocha HC, Figueira AVF, Mello ES de. Progressive familial intrahepatic cholestasis type 2 and recurrence after liver transplantation: a case report [Internet]. Transplantation proceedings. 2022 ; 54( 5): 1370-1375.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.transproceed.2022.04.007
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Andre et al. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, v. 274, p. 68-76, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jss.2022.01.001. Acesso em: 25 set. 2024.
APA
Lopes, A., Mello, E. S. de, Lopez, R. V. M., Leonardi, P. C., & Ribeiro Junior, U. (2022). Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, 274, 68-76. doi:10.1016/j.jss.2022.01.001
NLM
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001
Vancouver
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marina Alessandra et al. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer. Journal of surgical oncology, v. 121, n. 5, p. 795-803, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25785. Acesso em: 25 set. 2024.
APA
Pereira, M. A., Ramos, M. F. K. P., Dias, A. R., Cardili, L., Ribeiro, R. R. e, Charruf, A. Z., et al. (2020). Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer. Journal of surgical oncology, 121( 5), 795-803. doi:10.1002/jso.25785
NLM
Pereira MA, Ramos MFKP, Dias AR, Cardili L, Ribeiro RR e, Charruf AZ, Castria TB de, Zilberstein B, Cecconello I, Alves VAF, Ribeiro Junior U, Mello ES de. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 795-803.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25785
Vancouver
Pereira MA, Ramos MFKP, Dias AR, Cardili L, Ribeiro RR e, Charruf AZ, Castria TB de, Zilberstein B, Cecconello I, Alves VAF, Ribeiro Junior U, Mello ES de. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 795-803.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25785
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEIXOTO, Renata D'Alpino et al. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer. Ecancermedicalscience, v. 14, 2020Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2020.1126. Acesso em: 25 set. 2024.
APA
Peixoto, R. D. 'A., Rocha-filho, D. R., Weschenfelder, R. F., Rego, J. F. M., Riechelmann, R., Coutinho, A. K., et al. (2020). Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer. Ecancermedicalscience, 14. doi:10.3332/ecancer.2020.1126
NLM
Peixoto RD'A, Rocha-filho DR, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Mello ES de, Ribeiro Junior U. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2024 set. 25 ] Available from: https://doi.org/10.3332/ecancer.2020.1126
Vancouver
Peixoto RD'A, Rocha-filho DR, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Mello ES de, Ribeiro Junior U. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2024 set. 25 ] Available from: https://doi.org/10.3332/ecancer.2020.1126
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Diogo A et al. Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer. Bladder cancer, v. 6, n. 2, p. 171-186, 2020Tradução . . Disponível em: https://doi.org/10.3233/BLC-200289. Acesso em: 25 set. 2024.
APA
Bastos, D. A., Mattedi, R. L., Barreiro, R., Santos, F. F. dos, Buzatto, V., Masotti, C., et al. (2020). Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer. Bladder cancer, 6( 2), 171-186. doi:10.3233/BLC-200289
NLM
Bastos DA, Mattedi RL, Barreiro R, Santos FF dos, Buzatto V, Masotti C, Souza JM, Nahas WC, Mello ES de, Chammas R. Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer [Internet]. Bladder cancer. 2020 ; 6( 2): 171-186.[citado 2024 set. 25 ] Available from: https://doi.org/10.3233/BLC-200289
Vancouver
Bastos DA, Mattedi RL, Barreiro R, Santos FF dos, Buzatto V, Masotti C, Souza JM, Nahas WC, Mello ES de, Chammas R. Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer [Internet]. Bladder cancer. 2020 ; 6( 2): 171-186.[citado 2024 set. 25 ] Available from: https://doi.org/10.3233/BLC-200289
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIRQUEIRA, Cinthya Santos et al. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, v. 25, n. 4, p. 1363-1371, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12253-018-0386-8. Acesso em: 25 set. 2024.
APA
Cirqueira, C. S., Felipe-Silva, A. S., Wakamatsu, A., Marins, L. V., Rocha, E. C., Mello, E. S. de, & Alves, V. A. F. (2019). Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, 25( 4), 1363-1371. doi:10.1007/s12253-018-0386-8
NLM
Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.[citado 2024 set. 25 ] Available from: https://doi.org/10.1007/s12253-018-0386-8
Vancouver
Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.[citado 2024 set. 25 ] Available from: https://doi.org/10.1007/s12253-018-0386-8
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO JUNIOR, Gilberto de e HARADA, Guilherme e MELLO, Evandro Sobroza de. A importância da caracterização molecular no câncer de pulmão [Editorial]. Jornal brasileiro de pneumologia. Brasilia Df: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1590/1806-3713/e20190139. Acesso em: 25 set. 2024. , 2019
APA
Castro Junior, G. de, Harada, G., & Mello, E. S. de. (2019). A importância da caracterização molecular no câncer de pulmão [Editorial]. Jornal brasileiro de pneumologia. Brasilia Df: Faculdade de Medicina, Universidade de São Paulo. doi:10.1590/1806-3713/e20190139
NLM
Castro Junior G de, Harada G, Mello ES de. A importância da caracterização molecular no câncer de pulmão [Editorial] [Internet]. Jornal brasileiro de pneumologia. 2019 ; 45( 3):[citado 2024 set. 25 ] Available from: https://doi.org/10.1590/1806-3713/e20190139
Vancouver
Castro Junior G de, Harada G, Mello ES de. A importância da caracterização molecular no câncer de pulmão [Editorial] [Internet]. Jornal brasileiro de pneumologia. 2019 ; 45( 3):[citado 2024 set. 25 ] Available from: https://doi.org/10.1590/1806-3713/e20190139
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUSTAMANTE-LOPEZ, Leonardo Alfonso et al. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision. International journal of surgery, v. 56, p. 283-287, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ijsu.2018.07.001. Acesso em: 25 set. 2024.
APA
Bustamante-lopez, L. A., Mello, E. S. de, Ribeiro Junior, U., & Cecconello, I. (2018). Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision. International journal of surgery, 56, 283-287. doi:10.1016/j.ijsu.2018.07.001
NLM
Bustamante-lopez LA, Mello ES de, Ribeiro Junior U, Cecconello I. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision [Internet]. International journal of surgery. 2018 ; 56 283-287.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.ijsu.2018.07.001
Vancouver
Bustamante-lopez LA, Mello ES de, Ribeiro Junior U, Cecconello I. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision [Internet]. International journal of surgery. 2018 ; 56 283-287.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.ijsu.2018.07.001
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIAS, Andre R. et al. Lymph node yield after neoadjuvant chemoradiotherapy in rectal cancer specimens: a randomized trial comparing two fixatives. Diseases of the colon & rectum. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/DCR.0000000000001097. Acesso em: 25 set. 2024. , 2018
APA
Dias, A. R., Pereira, M. A., Mello, E. S. de, Nahas, S. C., Cecconello, I., & Ribeiro Junior, U. (2018). Lymph node yield after neoadjuvant chemoradiotherapy in rectal cancer specimens: a randomized trial comparing two fixatives. Diseases of the colon & rectum. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/DCR.0000000000001097
NLM
Dias AR, Pereira MA, Mello ES de, Nahas SC, Cecconello I, Ribeiro Junior U. Lymph node yield after neoadjuvant chemoradiotherapy in rectal cancer specimens: a randomized trial comparing two fixatives [Internet]. Diseases of the colon & rectum. 2018 ; 61( 8): 888-896.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/DCR.0000000000001097
Vancouver
Dias AR, Pereira MA, Mello ES de, Nahas SC, Cecconello I, Ribeiro Junior U. Lymph node yield after neoadjuvant chemoradiotherapy in rectal cancer specimens: a randomized trial comparing two fixatives [Internet]. Diseases of the colon & rectum. 2018 ; 61( 8): 888-896.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/DCR.0000000000001097
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Gilton M. et al. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases. Journal of surgical oncology, v. 117, n. 7, p. 1364-1375, 2018Tradução . . Disponível em: https://doi.org/10.1002/jso.25017. Acesso em: 25 set. 2024.
APA
Fonseca, G. M., Mello, E. S. de, Cecconello, I., Alves, V. A. F., & Herman, P. (2018). Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases. Journal of surgical oncology, 117( 7), 1364-1375. doi:10.1002/jso.25017
NLM
Fonseca GM, Mello ES de, Cecconello I, Alves VAF, Herman P. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases [Internet]. Journal of surgical oncology. 2018 ; 117( 7): 1364-1375.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25017
Vancouver
Fonseca GM, Mello ES de, Cecconello I, Alves VAF, Herman P. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases [Internet]. Journal of surgical oncology. 2018 ; 117( 7): 1364-1375.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25017
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marina Alessandra et al. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy. Chinese journal of cancer research, v. 30, n. 5, p. 526-536, 2018Tradução . . Disponível em: https://doi.org/10.21147/j.issn.1000-9604.2018.05.06. Acesso em: 25 set. 2024.
APA
Pereira, M. A., Ramos, M. F. K. P., Dias, A. R., Faraj, S. F., Cirqueira, C. dos S., Mello, E. S. de, et al. (2018). Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy. Chinese journal of cancer research, 30( 5), 526-536. doi:10.21147/j.issn.1000-9604.2018.05.06
NLM
Pereira MA, Ramos MFKP, Dias AR, Faraj SF, Cirqueira C dos S, Mello ES de, Zilberstein B, Alves VAF, Ribeiro Jr. U. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy [Internet]. Chinese journal of cancer research. 2018 ; 30( 5): 526-536.[citado 2024 set. 25 ] Available from: https://doi.org/10.21147/j.issn.1000-9604.2018.05.06
Vancouver
Pereira MA, Ramos MFKP, Dias AR, Faraj SF, Cirqueira C dos S, Mello ES de, Zilberstein B, Alves VAF, Ribeiro Jr. U. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy [Internet]. Chinese journal of cancer research. 2018 ; 30( 5): 526-536.[citado 2024 set. 25 ] Available from: https://doi.org/10.21147/j.issn.1000-9604.2018.05.06
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PESSORRUSSO, Fernanda Cristina Simoes et al. Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteria. Gastrointestinal endoscopy, v. 88, n. 6, p. 912-918, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.gie.2018.07.023. Acesso em: 25 set. 2024.
APA
Pessorrusso, F. C. S., Felipe-silva, A., Jacob, C. E., Ramos, M. F. K. P., Ferreira, V. A. A., Mello, E. S. de, et al. (2018). Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteria. Gastrointestinal endoscopy, 88( 6), 912-918. doi:10.1016/j.gie.2018.07.023
NLM
Pessorrusso FCS, Felipe-silva A, Jacob CE, Ramos MFKP, Ferreira VAA, Mello ES de, Zilberstein B, Ribeiro Junior U, Maluf-Filho F. Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteria [Internet]. Gastrointestinal endoscopy. 2018 ; 88( 6): 912-918.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.gie.2018.07.023
Vancouver
Pessorrusso FCS, Felipe-silva A, Jacob CE, Ramos MFKP, Ferreira VAA, Mello ES de, Zilberstein B, Ribeiro Junior U, Maluf-Filho F. Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteria [Internet]. Gastrointestinal endoscopy. 2018 ; 88( 6): 912-918.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.gie.2018.07.023
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Gilton M. et al. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology, v. 72, n. 3, p. 377-390, 2018Tradução . . Disponível em: https://doi.org/10.1111/his.13378. Acesso em: 25 set. 2024.
APA
Fonseca, G. M., Herman, P., Cecconello, I., Alves, V. A. F., & Mello, E. S. de. (2018). Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology, 72( 3), 377-390. doi:10.1111/his.13378
NLM
Fonseca GM, Herman P, Cecconello I, Alves VAF, Mello ES de. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol [Internet]. Histopathology. 2018 ; 72( 3): 377-390.[citado 2024 set. 25 ] Available from: https://doi.org/10.1111/his.13378
Vancouver
Fonseca GM, Herman P, Cecconello I, Alves VAF, Mello ES de. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol [Internet]. Histopathology. 2018 ; 72( 3): 377-390.[citado 2024 set. 25 ] Available from: https://doi.org/10.1111/his.13378
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marina Alessandra et al. Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment. Journal of gastrointestinal surgery, v. 22, n. 1, p. 23-31, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11605-017-3517-8. Acesso em: 25 set. 2024.
APA
Pereira, M. A., Zilberstein, B., Cecconello, I., Mello, E. S. de, & Ribeiro Junior, U. (2018). Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment. Journal of gastrointestinal surgery, 22( 1), 23-31. doi:10.1007/s11605-017-3517-8
NLM
Pereira MA, Zilberstein B, Cecconello I, Mello ES de, Ribeiro Junior U. Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment [Internet]. Journal of gastrointestinal surgery. 2018 ; 22( 1): 23-31.[citado 2024 set. 25 ] Available from: https://doi.org/10.1007/s11605-017-3517-8
Vancouver
Pereira MA, Zilberstein B, Cecconello I, Mello ES de, Ribeiro Junior U. Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment [Internet]. Journal of gastrointestinal surgery. 2018 ; 22( 1): 23-31.[citado 2024 set. 25 ] Available from: https://doi.org/10.1007/s11605-017-3517-8
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANILOVIC, Debora Lucia Seguro et al. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: activation of antioxidative pathway in papillary thyroid carcinoma. Head and neck-journal for the sciences and specialties of the head and neck, v. 40, n. 6, p. 1271-1278, 2018Tradução . . Disponível em: https://doi.org/10.1002/hed.25105. Acesso em: 25 set. 2024.
APA
Danilovic, D. L. S., Mello, E. S. de, Frazzato, E. S. T., Wakamatsu, A., Jorge, A. A. de L., Hoff, A. O., & Marui, S. (2018). Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: activation of antioxidative pathway in papillary thyroid carcinoma. Head and neck-journal for the sciences and specialties of the head and neck, 40( 6), 1271-1278. doi:10.1002/hed.25105
NLM
Danilovic DLS, Mello ES de, Frazzato EST, Wakamatsu A, Jorge AA de L, Hoff AO, Marui S. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: activation of antioxidative pathway in papillary thyroid carcinoma [Internet]. Head and neck-journal for the sciences and specialties of the head and neck. 2018 ; 40( 6): 1271-1278.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/hed.25105
Vancouver
Danilovic DLS, Mello ES de, Frazzato EST, Wakamatsu A, Jorge AA de L, Hoff AO, Marui S. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: activation of antioxidative pathway in papillary thyroid carcinoma [Internet]. Head and neck-journal for the sciences and specialties of the head and neck. 2018 ; 40( 6): 1271-1278.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/hed.25105
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Gilton M. et al. Reply to ""Poorly differentiated clusters in colorectal liver metastases [Carta]: prognostic significance in synchronous and metachronous metastases"". Journal of surgical oncology. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/jso.25079. Acesso em: 25 set. 2024. , 2018
APA
Fonseca, G. M., Mello, E. S. de, Coelho, F. F., Kruger, J. A. P., Faraj, S. F., Jeismann, V. B., et al. (2018). Reply to ""Poorly differentiated clusters in colorectal liver metastases [Carta]: prognostic significance in synchronous and metachronous metastases"". Journal of surgical oncology. Hoboken: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/jso.25079
NLM
Fonseca GM, Mello ES de, Coelho FF, Kruger JAP, Faraj SF, Jeismann VB, Pawlik TM, Herman P. Reply to ""Poorly differentiated clusters in colorectal liver metastases [Carta]: prognostic significance in synchronous and metachronous metastases"" [Internet]. Journal of surgical oncology. 2018 ; 117( 8): 1858-1859.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25079
Vancouver
Fonseca GM, Mello ES de, Coelho FF, Kruger JAP, Faraj SF, Jeismann VB, Pawlik TM, Herman P. Reply to ""Poorly differentiated clusters in colorectal liver metastases [Carta]: prognostic significance in synchronous and metachronous metastases"" [Internet]. Journal of surgical oncology. 2018 ; 117( 8): 1858-1859.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/jso.25079